DC EKG
Joe and Eric explore and explain “the what and why” of Washington. Through thoughtful interviews with inside the room experts, they shine a light on the black box of DC and break down healthcare issues and policy areas that shape the federal budget, politics, and how they intersect with health policy.
Episodes
October 2, 2023 • 21 mins
This episode explores the enormous historical figure that is Justice Clarence Thomas. Insights on his story are detailed in a discussion about the book Mark co-wrote/edited, Created Equal: Clarence Thomas in His Own Words, which discusses Justice Thomas’s early life surviving the deepest of challenges of poverty. We also explored Justice Thomas’s experience being taught by Irish nuns and the profound and systemic racism he experien...
Mark as Played
September 25, 2023 • 20 mins
This episode covers how the Congress can investigate the FTX scandal, the need to learn what happened with the botched and tragic pullout from Afghanistan, and how to begin the examination of the government’s actions regarding Covid-19. The best ways to conduct an examination of public health mistakes of the last few years include examination of free speech suppression; the conduct of large bureaucracies; the lockdown of schools, a...
Mark as Played
September 18, 2023 • 37 mins
Joe and Eric review breaking news out of Washington. Eric gives a deep cut on the spending crisis and what is in store for both the house andpp senate. Plus McCarthy grief.
Mark as Played
September 11, 2023 • 19 mins
Over the next three episodes Joe and Eric speak with Mark Paoletta, a distinguished attorney in Washington, a former oversight lawyer on Capitol Hill, and the editor/author of the book Created Equal: Clarence Thomas in his Own Words. This episode explores how the new Republican House majority should conduct oversight. The discussion centered on Mark’s experience investigating the malfeasance at Enron, WorldCom, and Global Crossing,...
Mark as Played
September 5, 2023 • 20 mins
Common misconceptions and why pharmaceutical market is so different. List price, co pays and deductibles, oh my. Bio similars v small molecule, how the evolution here promises great things. Competition is real and generates real savings, and deflation. Opportunity for savings was real, IRA causing disruption to that. Cell and gene therapies are just the latest revolution for patients therapies: branded drugs, generic medicines, sma...
Mark as Played
August 28, 2023 • 21 mins
Discussed: Batch processing versus Continuous flow technology to onshore manufacturing of medicine. The way we increase the reliability of the supply chain is embrace innovation and bring this close to home. National security is improved as well. Supply driven shortages is again a factor, replacing the Covid crisis “demand “driven shortages. On, or near, shore needs to continue. Also discussed: Manufacturing is facing R&D impacts a...
Mark as Played
August 21, 2023 • 21 mins
Who better to hear from about the condition of the condition of shortages dogging the healthcare supply chain than someone closest to the issue. David Senior is a longtime official with AmerisourceBergen, one of the world’s largest players in that chain. He discusses the historical challenges as well as the pressures of deflation on supply.
Mark as Played
August 14, 2023 • 22 mins
Naomi wraps the third segment with a flourish of innovative thought. About how much value is being added by the latest developments in medicine, how the shrinking cost of most drugs are spurring market choices, and how states are driving some exciting developments in health public policy. Plus the importance of staying healthy as we age.
Mark as Played
August 7, 2023 • 21 mins
The conversation continues with helpful insights- and cautions- about regulating AI, observations about the ability of Washington to keep up with the pace of change, and how we need to reimagine our approach. Also the invidious efforts to ration cures through the IRA under the cover of price controls. Bureaucracies and political agendas are stepping in to decide that they know better than patients and doctors about the value of you...
Mark as Played
July 31, 2023 • 20 mins
Goldwater institute health expert, Naomi Lopez, shares her view on why artificial intelligence should not be feared, and can bring great advantages to medicine. elements of it have also been around for a long time, powering every day items like driver assist and crash avoidance. Naomi also talks about her work on behalf of “right to try” and the help it has delivered to people who have been frustrated by slow FDA approval’s.
Mark as Played
July 24, 2023 • 70 mins
Recorded on 7/20- the same day the Stamford University president was forced to resign - Dr. Jay offers comment (50:10) on the hostile work environment allowed on campus.
The sad and painful story of how the government, big tech, and academia conspired to suppress voices. Blacklisting at Twitter, ruined careers, and zero tolerance for questioning use of masks on children, the efficacy of vaccinees, and lockdowns. The federal governm...
Mark as Played
July 17, 2023 • 20 mins
The importance of growing the economy, the promise of AI, and why the future will brighter we needn’t be afraid.
Mark as Played
July 10, 2023 • 19 mins
The budget conversation continues with Paul. Here Joe and Eric press the question of the viability of maintaining such a large national debt and how economic growth is so vital. Currently the US is world’s leading asset today but we should de-risk our position by remaining a strong nation and drive economic growth. It’s Paul’s view that you cannot grow revenue faster than you grow the economy.
Mark as Played
July 3, 2023 • 21 mins
Paul shares his career history, the journey to his newly minted PhD, and useful context for today’s fiscal strife in DC. In this first part of a three-part conversation, Joe and Eric dive into what brought Paul to the fold of federal budget expertise, and useful top line takeaways from his London school of economics training.
Mark as Played
June 26, 2023 • 20 mins
In the third episode of this three-part discussion, Art shares details on his latest effort to help improve substance abuse treatment in the US. He began a nonprofit called the “Recovery Now” foundation. They also review current public policies branded as “harm reduction.” During this administration these measures are normalizing dependency and drug use, which in his view is the most effective way to break down the family unit. The...
Mark as Played
June 19, 2023 • 16 mins
In the second part of their three-part discussion, the discussion begins with what Art saw on his trip (August of 2022) to the southern border. Art shares how drug cartels monitor and control the border, use migrants who can’t afford the $6000 fee coyotes charge to smuggle them across the US, and the sophisticated tactics the cartels use to evade US border patrol. Art also unmasks the fallacy of public distribution of “test strips”...
Mark as Played
June 12, 2023 • 17 mins
This episode tackles one of the most important public policy issues facing the US today. Joe and Eric hold a three-part discussion with their guest Art Kleinschmidt, where they review the current opioid crisis, discuss what public policy and recovery look like, and explore Art’s story of how he lived as a recovering user himself. The following three episodes take place in September of 2022, and all three include information to sh...
Mark as Played
June 5, 2023 • 16 mins
Part III of Joe and Eric’s talk with economist Tomas Philipson focuses on his role as acting head of the Council of Economic Advisers from the start of the Covid crisis. What it was like to watch the “blue collar boom” and 3%+ GDP growth get undone by the pandemic, and how public health attitudes toward prevention at any cost, cost us dearly. And how the two tier approach (protect venerable / keep economy open) advocated by CEA l...
Mark as Played
May 29, 2023 • 21 mins
In the second part of a three-part interview, hosts Joe Grogan and Eric Ueland glean more gems from University of Chicago economist, Tom Philipson. Discussed are the damaging results of the two-year decline in US real wages, market volatility caused by government largesse, and the asymmetrical focus on bureaucrats over actual economic supply and demand metrics. Part one of this discussion begins with a unyielding dissection of the ...
Mark as Played
May 22, 2023 • 18 mins
From the public announcements of discontinued research, the fuzzy CBO math that is under-counting the reductions in cures, to the bloated use of taxpayer dollars to implement price control. Its a data rich discussion that's sure to send shivers down the spines of policymakers, practitioners , and patients alike.
Tom can be found: https://www.linkedin.com/in/tomas-j-philipson-02878024/
Mark as Played
Popular Podcasts
Current and classic episodes, featuring compelling true-crime mysteries, powerful documentaries and in-depth investigations.
If you can never get enough true crime... Congratulations, you’ve found your people.
NFL.com's "Around the NFL" crew (Gregg Rosenthal, Dan Hanzus and Marc Sessler) break down the latest football news, with a dash of mirth.
If you've ever wanted to know about champagne, satanism, the Stonewall Uprising, chaos theory, LSD, El Nino, true crime and Rosa Parks, then look no further. Josh and Chuck have you covered.
Listen to 'The Bobby Bones Show' by downloading the daily full replay.